Start Date
June 30, 2000
Primary Completion Date
January 31, 2007
Study Completion Date
January 31, 2007
filgrastim
monoclonal antibody 3F8
sargramostim
carboplatin
cisplatin
cyclophosphamide
doxorubicin hydrochloride
etoposide
isotretinoin
thiotepa
topotecan hydrochloride
vincristine sulfate
autologous bone marrow transplantation
bone marrow ablation with stem cell support
conventional surgery
drug resistance inhibition treatment
peripheral blood stem cell transplantation
syngeneic bone marrow transplantation
radiation therapy
Memorial Sloan-Kettering Cancer Center, New York
National Cancer Institute (NCI)
NIH
Memorial Sloan Kettering Cancer Center
OTHER